<div id="readability-page-1">04:44 PM EDT, 05/12/2026 (MT Newswires) -- SELLAS Life Sciences Group ( SLS ) reported a Q1 loss late Tuesday of $0.05 per diluted share, narrowing from a loss of $0.07 a year earlier.Two analysts polled by FactSet expected a loss of $0.06.Cash and cash equivalents were $107.1 million at the end of Q1, compared with $71.8 million at the end of Q4.Shares of the company rose more than 12% in after-hours activity. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

2026 年 5 月 12 日下午 4:44（東部夏令時間）——SELLAS Life Sciences Group（SLS）在週二晚間報告了第一季度每股攤薄虧損 0.05 美元，較去年同期的 0.07 美元虧損有所收窄。根據 FactSet 的調查，兩位分析師預計虧損為 0.06 美元。第一季度末現金及現金等價物為 1.071 億美元，而第四季度末為 7180 萬美元。該公司股票在盤後交易中上漲超過 12%。MT Newswires 不提供投資建議。未經授權的複製嚴格禁止

Sellas Life Sciences 集團第一季度虧損收窄